Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/130445
Full metadata record
DC FieldValueLanguage
dc.creatorLopes, G.
dc.creatorClarinha, D.
dc.creatorVasconcelos V.
dc.date.accessioned2020-12-04T15:17:10Z-
dc.date.available2020-12-04T15:17:10Z-
dc.date.issued2020
dc.identifier.issnISSN 2076-2607
dc.identifier.urihttps://hdl.handle.net/10216/130445-
dc.description.abstractIn this study, five cyanobacteria strains (Alkalinema aff. pantanalense LEGE15481, Cyanobium gracile LEGE12431, Nodosilinea (Leptolyngbya) antarctica LEGE13457, Cuspidothrix issatschenkoi LEGE03282 and Leptolyngbya-like sp. LEGE13412) from the Blue Biotechnology and Ecotoxicology Culture Collection (LEGE CC) of CIIMAR were explored for their biotechnological potential in the treatment of psoriasis. Different extracts were characterized for their pigment profile by HPLC-PDA. The antioxidant potential of the extracts was assessed against the superoxide anion radical (O2•-). Their anti-inflammatory and antiproliferative potential was assessed in vitro using the macrophages RAW 264.7 and the human keratinocytes HaCaT as cell-line models, respectively. Terrestrial and freshwater strains presented the highest carotenoid content (33193−63926 μg/g dry extract), with all-trans-β-carotene, zeaxanthin, echinenone and lutein derivatives being the most abundant carotenoids. Acetone was the most effective solvent for pigment extraction. The acetone extracts presented the lowest IC50 values (0.29−0.38 mg dry extract/mL) regarding O2•- scavenging, and revealed anti-inflammatory potential, with N. antarctica LEGE13457, A. pantanalense LEGE15481 and Leptolyngbya-like sp. LEGE13412 reducing the nitric oxide (NO) in RAW 264.7 cell culture medium in about 25% (p < 0.05). With the exception of A. pantanalense LEGE15481, all the extracts significantly reduced keratinocyte proliferation (p < 0.05), demonstrating a selective toxicity among the different cell lines. Overall, Leptolyngbya-like sp. LEGE13412 and N. antarctica LEGE13457 seem promising for further exploitation in the framework of psoriasis, due to their antioxidant, anti-inflammatory and antiproliferative potential.
dc.description.sponsorshipThis work was done in the framework of the project BLUEHUMAN–BLUE biotechnology as a road for innovation on HUMAN’s health aiming smart growth in Atlantic Area–EAPA_151/2016 of the Interreg Atlantic Area Programme funded by the European Regional Development Fund, and supported by the FCT Projects UIDB/04423/2020 and UIDP/04423/2020. The authors acknowledge the support and the use of resources of EMBRC-ERIC, specifically of the Portuguese infrastructure node of the European Marine Biological Resource Centre (EMBRC-PT) CIIMAR–PINFRA/22121/2016–ALG-01-0145-FEDER-022121, financed by the European Regional Development Fund (ERDF) through COMPETE2020-Operational Programme for Competitiveness and Internationalisation (POCI) and national funds through FCT/MCTES.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofMicroorganisms 2020, 8(2), 302
dc.rightsopenAccess
dc.subjectCarotenoids
dc.subjectCyanobacteria
dc.subjectInflammation
dc.subjectKeratinocytes
dc.subjectOxidative stress
dc.subjectPsoriasis
dc.titleCarotenoids from cyanobacteria: A biotechnological approach for the topical treatment of psoriasis
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoCentro Interdisciplinar de Investigação Marinha e Ambiental
dc.identifier.doihttps://doi.org/10.3390/microorganisms8020302
dc.relation.publisherversionhttps://www.mdpi.com/2076-2607/8/2/302
Appears in Collections:CIIMAR - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
Lopes_G_2020.pdf1.08 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.